Publication | Closed Access

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

Bone DiseaseBone BiomarkersBreast OncologyBone HealthMedicineBreast CancerMenopauseOsteoporosisIntergroup Exemestane StudyBone DensityOncologyFracture IncidenceOrthopaedic SurgeryCancer ResearchWomen's Health